Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study.

Source:http://linkedlifedata.com/resource/pubmed/id/10587327

Download in:

View as

General Info

PMID
10587327